Einige Inhalte dieser Seite sind nur für Abonnenten sichtbar.       Anmelden     oder      Jetzt abonnieren!

Archiv: Unternehmen

Genentech’s Fenebrutinib Maintains Near-Complete Suppression of Disease Activity and Disability Progression for up to Two Years in People With Relapsing Multiple Sclerosis » Report
CI Com: Annonce événementielle au sens de l'art. 53 RC » Report
Private Equity Holding AG: Annual General Meeting on June 24, 2025 in Zurich » Report
Private Equity Holding AG: Generalversammlung vom 24. Juni 2025 in Zürich » Report
Roche’s fenebrutinib maintains near-complete suppression of disease activity and disability progression for up to two years in people with relapsing multiple sclerosis » Report
GURIT ANNOUNCES CHANGES IN THE EXECUTIVE BOARD » Report
Meyer Burger shuts down solar module production and lays off 282 employees in the U.S. » Report
Meyer Burger stoppt Solarmodulproduktion und entlässt 282 Mitarbeitende in den USA » Report
Alcon - Alcon Announces FDA Approval of TRYPTYR (acoltremon ophthalmic solution) 0.003% for the Treatment of the Signs and Symptoms of Dry Eye Disease » Report
Logitech - SD (Specialized Disclosure Report) SEC Filing » Report
SHL announces 2025 Annual General Meeting Results » Report
Kuehne+Nagel Group: Kuehne+Nagel appoints new Global Head of Sales » Report
Glencore: Results of 2025 AGM » Report
Cantor Fitzgerald expands asset management capabilities with acquisition of UBS’s O’Connor alternatives investment platform » Report
Nestlé expands its air fryer range in the Americas, offering delicious meal moments » Report
Shareholders vote in favor of all proposals by the Board at Idorsia’s Annual General Meeting 2025 » Report
Galderma buys back shares worth CHF 233 million in the context of accelerated bookbuild offering » Report
Ascom launches share buyback program » Report
Ascom lanciert Aktienrückkaufprogramm » Report
Landis+Gyr veröffentlicht Geschäftsbericht 2024 und Einladung zur Generalversammlung 2025 » Report